SCHEMBL3972915

SCHEMBL3972915

COc1c(C=CC(=O)c2cc(C)cs2)c(C)c(C)c(C(=O)O)c1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.38
KDR P35968 3/20 0.36
TNFRSF1A P19438 3/20 0.36
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
CASP7 P55210 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
KRAS P01116 1/20 0.31
ABCB1 P08183 1/20 0.31
MAOB P27338 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4471372 0.87 DAO (0.41) DAOKDRTNFRSF1AALDH1A1KDM4E
SCHEMBL4465731 0.78 KDR (0.36) DAOKDRTNFRSF1AALDH1A1KDM4E
SCHEMBL3968383 0.77 MAOA (0.47) TNFRSF1AMEN1MAPTKMT2AKRAS
SCHEMBL498782 0.76 KDR (0.46) DAOKDRTNFRSF1AALDH1A1KDM4E
SCHEMBL3972913 0.75 PPARG (0.44) ALDH1A1KDM4EMEN1CYP3A4MAPT
SCHEMBL499187 0.67 KCNA3 (0.48) DAOTNFRSF1AALDH1A1MEN1CYP3A4
SCHEMBL498938 0.65 FNTA (0.39) DAOTNFRSF1AALDH1A1KDM4EMEN1
SCHEMBL3969210 0.64 APP (0.51) KDRMAOB
SCHEMBL29214717 0.63 CYP1A1 (0.55) MAOB
SCHEMBL28413554 0.62 PPARA (0.62) DAOKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566737-B2 Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2009-07-28 US claimed
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2007-02-08 US claimed
US-7566737-B2 Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2009-07-28 US disclosed
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients PSEN1, BACE1, PSEN2 DAO 3267/4885KDR 150/4885TNFRSF1A 2548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.